Old medications and new targeted therapies in systemic sclerosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25065013.
- Also identified by DOI 10.1093/rheumatology/keu285 and PMC identifier 4603276.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
SSc is a multiorgan disease with significant morbidity that is associated with poor health-related quality of life. Treatment of this condition is often organ based and non-curative. However, there are newer, potentially disease-modifying therapies available to treat certain aspects of the disease. This review focuses on old and new therapies in the management of SSc in clinical practice.
Medical subject headings
- Antirheumatic Agents
- Drug Therapy
- Scleroderma, Systemic